Form4insider filings, from the source

Insider holders · CIK 0000025743

TherapeuticsMD, Inc. · TXMD

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Robert G FinizioCEO18,366,559664,86419,031,423Dec 21, 2018 · 8:02 pm ESTForm 4
John C.K. Milligan IVPresident/Secretary1,472,4193,557,3735,029,792Dec 19, 2018 · 8:01 pm ESTForm 4
Brian BernickDirector52,0003,00055,000Dec 14, 2018 · 8:01 pm ESTForm 4
Angus C. RussellDirector48,500—48,500Aug 27, 2015 · 4:31 pm EDTForm 4
Daniel A CartwrightCFO40,000—40,000Dec 10, 2018 · 8:02 pm ESTForm 4
Cooper C. CollinsDirector36,000—36,000Mar 14, 2016 · 5:01 pm EDTForm 4
J Martin CarrollDirector10,000—10,000May 12, 2015 · 4:35 pm EDTForm 4
Jules A. MusingDirector5,000—5,000Mar 1, 2019 · 5:30 pm ESTForm 4
Tommy G ThompsonDirector3,5551,0014,556Aug 23, 2018 · 4:32 pm EDTForm 4
Mitchell KrassanEVP, Chief Strategy Officer0—0Jun 10, 2015 · 6:22 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.